Literature DB >> 17135807

ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials.

David P Salmon1, Jeffrey L Cummings, Shelia Jin, Mary Sano, Reisa A Sperling, Edward Zamrini, Ronald C Petersen, Steven D Edland, Leon J Thal, Steven H Ferris.   

Abstract

The validity and reliability of clinic-based and telephone-based versions of a 4 word delayed recall test were evaluated in nondemented elderly individuals (n=644) participating in a simulated primary prevention clinical trial. There was no significant difference in the average scores achieved by participants tested in clinic (mean=3.40) or by telephone (mean=3.47) and the 2 groups had similar distributions of scores. Delayed recall scores were significantly, but weakly, correlated with scores on a rigorous verbal memory task, were lower in participants in Clinical Dementia Rating stage 0.5 than in those in Clinical Dementia Rating stage 0, and were lower in those with subjective memory complaints than in those without complaints. There was only fair correspondence between scores achieved at initial testing and 3 months later for both versions of the test. There were no differences in the average scores achieved by men or women, those older (age 80 to 93) or younger (age 75 to 79) than age 80, or those with white or nonwhite ethnicity. Participants with low education scored significantly lower than those with high education. Results suggest that clinic-based and telephone-based versions of the Four Word Delayed Recall Test are valid and reliable and can be used to screen for possible memory deficits in elderly individuals. However, the psychometric properties of the test are relatively weak and do not support the general use of the test for clinical and research purposes if the use of a more rigorous memory test with a wider range of possible scores is feasible.

Entities:  

Mesh:

Year:  2006        PMID: 17135807     DOI: 10.1097/01.wad.0000213871.40300.68

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  4 in total

1.  Choosing Alzheimer's disease prevention clinical trial populations.

Authors:  Joshua D Grill; Sarah E Monsell
Journal:  Neurobiol Aging       Date:  2013-10-09       Impact factor: 4.673

2.  Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old.

Authors:  Mary Sano; Susan Egelko; Steven Ferris; Jeffrey Kaye; Tamara L Hayes; James C Mundt; Michael Donohue; Sarah Walter; Shelly Sun; Luis Sauceda-Cerda
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

3.  The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.

Authors:  Clara Li; Judith Neugroschl; Xiaodong Luo; Carolyn Zhu; Paul Aisen; Steven Ferris; Mary Sano
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Developing dementia prevention trials: baseline report of the Home-Based Assessment study.

Authors:  Mary Sano; Susan Egelko; Michael Donohue; Steven Ferris; Jeffrey Kaye; Tamara L Hayes; James C Mundt; Chung-Kai Sun; Silvia Paparello; Paul S Aisen
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Oct-Dec       Impact factor: 2.703

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.